References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Chen W, Sun K, Zheng R, Zeng H, Zhang S, Xia C, Yang Z, Li H, Zou X, He J. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1–12. doi:https://doi.org/10.21147/j.issn.1000-9604.2018.01.01
- Pallis AG, Syrigos KN. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol. 2013;88(3):494–503. doi:https://doi.org/10.1016/j.critrevonc.2013.06.011
- Xiang D, Zhang B, Doll D, Shen K, Kloecker G, Freter C. Lung cancer screening: from imaging to biomarker. Biomark Res. 2013;1(1):4doi:https://doi.org/10.1186/2050-7771-1-4
- Koutsokera A, Kiagia M, Saif MW, Souliotis K, Syrigos KN. Nutrition habits, physical activity, and lung cancer: an authoritative review. Clin Lung Cancer. 2013;14(4):342–50. doi:https://doi.org/10.1016/j.cllc.2012.12.002
- Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–256. doi:10.1017/s002966510800712x
- Mao S, Huang S. Zinc and copper levels in bladder cancer: a systematic review and meta-analysis. Biol Trace Elem Res. 2013;153(1-3):5–10. doi:https://doi.org/10.1007/s12011-013-9682-z
- Stepien M, Hughes DJ, Hybsier S, Bamia C, Tjønneland A, Overvad K, Affret A, His M, Boutron-Ruault M-C, Katzke V, et al. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans. Br J Cancer. 2017;116(5):688–696. doi:https://doi.org/10.1038/bjc.2017.1
- Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem. 2004;15(10):572–578. doi:https://doi.org/10.1016/j.jnutbio.2004.07.005
- Osredkar J. Copper and zinc, biological role and significance of copper/zinc imbalance. J Clin Toxicol. 2011;s3(01):1–18. doi:https://doi.org/10.4172/2161-0495.S3-001
- Zabłocka-Słowińska K, Płaczkowska S, Prescha A, Pawełczyk K, Porębska I, Kosacka M, Pawlik-Sobecka L, Grajeta H. Serum and whole blood Zn, Cu and Mn profiles and their relation to redox status in lung cancer patients. J Trace Elem Med Biol. 2018;45:78–84. doi:https://doi.org/10.1016/j.jtemb.2017.09.024
- Aguirre JD, Culotta VC. Battles with iron: manganese in oxidative stress protection. J Biol Chem. 2012;287(17):13541–8. doi:https://doi.org/10.1074/jbc.R111.312181
- Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci. 2008;99(8):1515–22. doi:https://doi.org/10.1111/j.1349-7006.2008.00854.x
- Oyama T, Matsuno K, Kawamoto T, Mitsudomi T, Shirakusa T, Kodama Y. Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol Trace Elem Res. 1994;42(2):115–27. doi:https://doi.org/10.1007/BF02785383
- Piccinini L, Borella P, Bargellini A, Medici CI, Zoboli A. A case-control study on selenium, zinc, and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Elem Res. 1996;51(1):23–30. doi:https://doi.org/10.1007/BF02790144
- Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35(1):32–46. doi:https://doi.org/10.1016/j.ctrv.2008.07.004
- Borella P, Bargellini A, Caselgrandi E, Piccinini L. Observations on the use of plasma, hair and tissue to evaluate trace element status in cancer. J Trace Elem Med Biol. 1997;11(3):162–5. doi:https://doi.org/10.1016/S0946-672X(97)80046-6
- Jin Y, Zhang C, Xu H, Xue S, Wang Y, Hou Y, Kong Y, Xu Y. Combined effects of serum trace metals and polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: a hospital based case-control study in China. Cancer Epidemiol. 2011;35(2):182–7. doi:https://doi.org/10.1016/j.canep.2010.06.004
- Bai Y, Wang G, Fu W, Lu Y, Wei W, Chen W, Wu X, Meng H, Feng Y, Liu Y, et al. Circulating essential metals and lung cancer: risk assessment and potential molecular effects. Environ Int. 2019;127:685–693.:doi:https://doi.org/10.1016/j.envint.2019.04.021
- Zhang H-q, Li N, Zhang Z, Gao S, Yin H-y, Guo D-m, Gao X. Serum zinc, copper, and zinc/copper in healthy residents of Jinan. Biol Trace Elem Res. 2009;131(1):25–32. doi:https://doi.org/10.1007/s12011-009-8350-9
- Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20(1):3–18. doi:https://doi.org/10.1016/j.jtemb.2006.01.006
- Luo J, Meng J, Ye Y, Wang Y, Bai L. Population health risk via dietary exposure to trace elements (Cu, Zn, Pb, Cd, Hg, and As) in Qiqihar, Northeastern China. Environ Geochem Health. 2018;40(1):217–227. doi:https://doi.org/10.1007/s10653-016-9895-0
- Yan SC. Determination of trace elements in human serum by inductively coupled plasma mass spectrometry with direct dilution method. J Instrum Anal. 2018;37:346–349.
- Zj H. Detection of serum trace elements in patients with lung cancer and its significance. Med Innov China. 2011;8:118–119.
- Zhang LL, X M, Li JH, Wei FS, Wu GP, Wang XQ. Study on the Relationship between Copper Exposure and Lung Cancer in Qujing Area, Yunnan Province. Asian J Ecotoxicol. 2014;9:765–773. doi:https://doi.org/10.7524/AJE.1673-5897.20140311001
- Xu LH, W Y, Jiang YY. Relationship between serum copper, zinc levels and Zps score, prognosis. J Pract Oncol. 2009;24:183–186. doi:https://doi.org/10.13267/j.cnki.syzlzz.2009.02.025
- Zb H. Methods and clinical significance of serum detection in patients with lung cancer. J Clin Hematol. 2012;25:234–235. doi:https://doi.org/10.13201/j.issn.1004-2806-b.2012.02.033
- Ying Z, L X. Relationship of serum trace elements to lung cancer. Studies of Trace Elements and Health. 2000;17:15–17.
- Li W, J Q. The role of copper and zinc determination in patients with lung cancer. Bull Chin Cancer. 2002;11:182–183. doi:https://doi.org/10.3969/j.issn.1004-0242.2002.03.033
- Poukkula A, Hakala M, Huhti E. Serum copper, zinc and ceruloplasmin concentrations in patients with lung cancer. Respiration. 1987;51(4):272–6. doi:https://doi.org/10.1159/000195213
- Zhang X, Yang Q. Association between serum copper levels and lung cancer risk: A meta-analysis. J Int Med Res. 2018;46(12):4863–4873. doi:https://doi.org/10.1177/0300060518798507
- Wang Y, Sun Z, Li A, Zhang Y. Association between serum zinc levels and lung cancer: a meta-analysis of observational studies. World J Surg Oncol. 2019;17(1):78–78. doi:https://doi.org/10.1186/s12957-019-1617-5
- Díez M, Arroyo M, Cerdàn FJ, Muñoz M, Martin MA, Balibrea JL. Serum and tissue trace metal levels in lung cancer. Oncology. 1989;46(4):230–234. doi:https://doi.org/10.1159/000226722
- Zowczak M, Iskra M, Torliński L, Cofta S. Analysis of serum copper and zinc concentrations in cancer patients. Biol Trace Elem Res. 2001;82(1-3):1–8. doi:https://doi.org/10.1385/bter:82:1-3:001
- Li YK, W H, Zeng XC, Huang KN, Bai ZC. The diagnostic value of ROC curve and Independent-sample T test of trace elements in Lung cancer. Comput Appl Chem. 2017;34:376–378. doi:https://doi.org/10.16866/j.com.app.chem201705007
- Zhou XiL WX, Zs LI, Ml Z, Yl YUAN, Wu YJ. Study of decision tree model based on ten tumor markers in the diagnosis of lung cancer. Chin J Med Guide. 2018;20:641–645.
- Cobanoglu U, Demir H, Sayir F, Duran M, Mergan D. Some mineral, trace element and heavy metal concentrations in lung cancer. Asian Pac J Cancer Prev. 2010;11:1383–8.
- Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: 'copper that cancer'. Metallomics. 2015;7(11):1459–76. doi:https://doi.org/10.1039/c5mt00149h
- Fisher GL, Shifrine M. Hypothesis for the mechanism of elevated serum copper in cancer patients. Oncology. 1978;35(1):22–5. doi:https://doi.org/10.1159/000225249
- Gupta SK, Singh SP, Shukla VK. Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder. J Surg Oncol. 2005;91(3):204–8. doi:https://doi.org/10.1002/jso.20306
- King JC. Zinc: an essential but elusive nutrient. Am J Clin Nutr. 2011;94(2):679S–84s. doi:https://doi.org/10.3945/ajcn.110.005744
- Margalioth EJ, Schenker JG, Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer. 1983;52(5):868–72. doi:https://doi.org/10.1002/1097-0142(19830901)52:5 < 868::aid-cncr2820520521 > 3.0.co;2-k
- Oyama T, Kawamoto T, Matsuno K, Osaki T, Matsumoto A, Isse T, Nakata S, Ozaki S, Sugaya M, Yasuda M, et al. A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients. Anticancer Res. 2003;23(1B):605–12. :
- Díez M, Cerdà FJ, Arroyo M, Balibrea JL. Use of the copper/zinc ratio in the diagnosis of lung cancer. Cancer. 1989;63(4):726–30. doi:https://doi.org/10.1002/1097-0142(19890215)63:4 < 726::aid-cncr2820630421 > 3.0.co;2-p
- Brewer GJ. Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov Today. 2005;10(16):1103–9. doi:https://doi.org/10.1016/s1359-6446(05)03541-5
- Soncin F, Guitton J-D, Cartwright T, Badet J. Interaction of Human Angiogenin with Copper Modulates Angiogenin Binding to Endothelial Cells. Biochem Biophys Res Commun. 1997;236(3):604–610. doi:https://doi.org/10.1006/bbrc.1997.7018
- Hu GF. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem. 1998;69(3):326–35. doi:https://doi.org/10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A